Fund profile
Tickers
IBRN
Fund manager
Total assets
$4.83 mm
Liabilities
$999.34 k
Net assets
$3.83 mm
Number of holdings
43.00
IBRN stock data
43 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
BlackRock Cash Funds: Institutional, SL Agency Shares | 497.75 k | 497.45 k shares | 13.01 | Short-term investment vehicle | Long | USA |
CERE Cerevel Therapeutics Holdings Inc | 211.18 k | 5.04 k shares | 5.52 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 209.05 k | 667.00 shares | 5.46 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 184.67 k | 1.55 k shares | 4.83 | Common equity | Long | USA |
Biohaven Ltd
|
173.16 k | 3.89 k shares | 4.52 | Common equity | Long | Virgin Islands (British) |
XENE Xenon Pharmaceuticals Inc | 161.03 k | 3.56 k shares | 4.21 | Common equity | Long | Canada |
NBIX Neurocrine Biosciences, Inc. | 156.40 k | 1.12 k shares | 4.09 | Common equity | Long | USA |
AXNX Axonics Inc | 154.70 k | 2.28 k shares | 4.04 | Common equity | Long | USA |
Neuren Pharmaceuticals Ltd
|
151.95 k | 9.92 k shares | 3.97 | Common equity | Long | New Zealand |
ACAD Acadia Pharmaceuticals Inc | 150.25 k | 5.80 k shares | 3.93 | Common equity | Long | USA |
Alkermes PLC
|
145.93 k | 5.40 k shares | 3.81 | Common equity | Long | Ireland |
PTCT PTC Therapeutics Inc | 142.53 k | 5.46 k shares | 3.72 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 140.40 k | 2.09 k shares | 3.67 | Common equity | Long | USA |
SK Biopharmaceuticals Co Ltd
|
139.33 k | 2.01 k shares | 3.64 | Common equity | Long | Korea, Republic of |
BIIB Biogen Inc | 137.88 k | 559.00 shares | 3.60 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals Inc | 130.01 k | 4.70 k shares | 3.40 | Common equity | Long | USA |
IART Integra Lifesciences Holdings Corp | 127.88 k | 3.19 k shares | 3.34 | Common equity | Long | USA |
H Lundbeck A/S
|
122.10 k | 24.11 k shares | 3.19 | Common equity | Long | Denmark |
CPRX Catalyst Pharmaceuticals Inc | 118.40 k | 8.22 k shares | 3.09 | Common equity | Long | USA |
ARGX Argen X SE | 109.97 k | 289.00 shares | 2.87 | Common equity | Long | Netherlands |
AVDL Avadel Pharmaceuticals plc | 108.28 k | 7.53 k shares | 2.83 | Common equity | Long | Ireland |
HRMY Harmony Biosciences Holdings Inc | 93.83 k | 2.98 k shares | 2.45 | Common equity | Long | USA |
SAVA Cassava Sciences Inc | 85.00 k | 3.55 k shares | 2.22 | Common equity | Long | USA |
BioArctic AB
|
75.81 k | 3.50 k shares | 1.98 | Common equity | Long | Sweden |
AMLX Amylyx Pharmaceuticals Inc | 71.44 k | 4.47 k shares | 1.87 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corp | 68.91 k | 4.94 k shares | 1.80 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 59.86 k | 2.80 k shares | 1.56 | Common equity | Long | USA |
EWTX Edgewise Therapeutics Inc | 57.36 k | 3.22 k shares | 1.50 | Common equity | Long | USA |
NVRO Nevro Corp | 51.85 k | 3.13 k shares | 1.35 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corporation | 42.58 k | 7.13 k shares | 1.11 | Common equity | Long | USA |
AXGN Axogen Inc. | 35.43 k | 3.66 k shares | 0.93 | Common equity | Long | USA |
ALEC Alector Inc | 32.34 k | 5.43 k shares | 0.85 | Common equity | Long | USA |
WaVe Life Sciences Ltd
|
28.22 k | 6.53 k shares | 0.74 | Common equity | Long | Singapore |
TRDA Entrada Therapeutics Inc | 23.36 k | 1.60 k shares | 0.61 | Common equity | Long | USA |
VYGR Voyager Therapeutics Inc | 22.57 k | 3.11 k shares | 0.59 | Common equity | Long | USA |
CVRX CVRx Inc | 20.60 k | 820.00 shares | 0.54 | Common equity | Long | USA |
VNDA Vanda Pharmaceuticals Inc | 17.84 k | 4.96 k shares | 0.47 | Common equity | Long | USA |
ANNX Annexon Inc | 14.72 k | 3.54 k shares | 0.38 | Common equity | Long | USA |
Cellivery Therapeutics Inc
|
14.27 k | 3.57 k shares | 0.37 | Common equity | Long | Korea, Republic of |
ABOS Acumen Pharmaceuticals Inc | 11.36 k | 3.57 k shares | 0.30 | Common equity | Long | USA |
DSGN Design Therapeutics Inc | 6.85 k | 2.89 k shares | 0.18 | Common equity | Long | USA |
BTAI BioXcel Therapeutics Inc | 5.80 k | 1.80 k shares | 0.15 | Common equity | Long | USA |
MICRO EMIN RUS2000MAR24 | -259.72 | 1.00 contracts | -0.01 | Equity derivative | N/A | USA |